The role of glial cells in multiple sclerosis disease progression

Volume: 18, Issue: 4, Pages: 237 - 248
Published: Feb 21, 2022
Abstract
Despite the development of highly effective treatments for relapsing-remitting multiple sclerosis (MS), limited progress has been made in addressing primary progressive or secondary progressive MS, both of which lead to loss of oligodendrocytes and neurons and axons, and to irreversible accumulation of disability. Neuroinflammation is central to all forms of MS. The current effective therapies for relapsing-remitting MS target the peripheral...
Paper Details
Title
The role of glial cells in multiple sclerosis disease progression
Published Date
Feb 21, 2022
Volume
18
Issue
4
Pages
237 - 248
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.